• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于 mRNA 的具有改进转染效率的杂交生物聚合物和脂质纳米粒子。

Hybrid Biopolymer and Lipid Nanoparticles with Improved Transfection Efficacy for mRNA.

机构信息

Department of Pharmaceutics and Biopharmaceutics, Johannes Gutenberg University Mainz, D-55131 Mainz, Germany.

BioNTech RNA Pharmaceuticals, D-55131 Mainz, Germany.

出版信息

Cells. 2020 Sep 5;9(9):2034. doi: 10.3390/cells9092034.

DOI:10.3390/cells9092034
PMID:32899484
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7563888/
Abstract

Hybrid nanoparticles from lipidic and polymeric components were assembled to serve as vehicles for the transfection of messenger RNA (mRNA) using different portions of the cationic lipid DOTAP (1,2-Dioleoyl-3-trimethylammonium-propane) and the cationic biopolymer protamine as model systems. Two different sequential assembly approaches in comparison with a direct single-step protocol were applied, and molecular organization in correlation with biological activity of the resulting nanoparticle systems was investigated. Differences in the structure of the nanoparticles were revealed by thorough physicochemical characterization including small angle neutron scattering (SANS), small angle X-ray scattering (SAXS), and cryogenic transmission electron microscopy (cryo-TEM). All hybrid systems, combining lipid and polymer, displayed significantly increased transfection in comparison to lipid/mRNA and polymer/mRNA particles alone. For the hybrid nanoparticles, characteristic differences regarding the internal organization, release characteristics, and activity were determined depending on the assembly route. The systems with the highest transfection efficacy were characterized by a heterogenous internal organization, accompanied by facilitated release. Such a system could be best obtained by the single step protocol, starting with a lipid and polymer mixture for nanoparticle formation.

摘要

脂质体和聚合物混合纳米颗粒被组装起来,用作信使 RNA(mRNA)转染的载体,使用不同比例的阳离子脂质 DOTAP(1,2-二油酰基-3-三甲基铵丙烷)和阳离子生物聚合物鱼精蛋白作为模型系统。与直接的单步方案相比,应用了两种不同的顺序组装方法,并研究了与所得纳米颗粒系统的生物活性相关的分子组织。通过包括小角中子散射(SANS)、小角 X 射线散射(SAXS)和低温透射电子显微镜(cryo-TEM)在内的彻底物理化学特性研究,揭示了纳米颗粒的结构差异。与单独的脂质/mRNA 和聚合物/mRNA 颗粒相比,所有结合脂质和聚合物的混合系统的转染效率均显著提高。对于混合纳米颗粒,根据组装路线,确定了内部组织、释放特性和活性的特征差异。转染效率最高的系统具有异质的内部组织,并伴有促进释放。通过从脂质和聚合物混合物开始形成纳米颗粒的单步方案,可以获得这种具有最高转染效率的系统。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f564/7563888/aa73f929219e/cells-09-02034-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f564/7563888/ae5032135d20/cells-09-02034-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f564/7563888/ccfe94aac5ac/cells-09-02034-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f564/7563888/31b559734bdc/cells-09-02034-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f564/7563888/5fbd8435af08/cells-09-02034-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f564/7563888/aa73f929219e/cells-09-02034-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f564/7563888/ae5032135d20/cells-09-02034-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f564/7563888/ccfe94aac5ac/cells-09-02034-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f564/7563888/31b559734bdc/cells-09-02034-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f564/7563888/5fbd8435af08/cells-09-02034-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f564/7563888/aa73f929219e/cells-09-02034-g005.jpg

相似文献

1
Hybrid Biopolymer and Lipid Nanoparticles with Improved Transfection Efficacy for mRNA.用于 mRNA 的具有改进转染效率的杂交生物聚合物和脂质纳米粒子。
Cells. 2020 Sep 5;9(9):2034. doi: 10.3390/cells9092034.
2
Mechanistic understanding of gene delivery mediated by highly efficient multicomponent envelope-type nanoparticle systems.高效多组分包膜型纳米粒子系统介导基因传递的机制理解。
Mol Pharm. 2013 Dec 2;10(12):4654-65. doi: 10.1021/mp400470p. Epub 2013 Nov 15.
3
Characterization of cationic lipid DNA transfection complexes differing in susceptability to serum inhibition.对血清抑制敏感性不同的阳离子脂质体DNA转染复合物的表征
BMC Biotechnol. 2002 Jul 12;2:12. doi: 10.1186/1472-6750-2-12.
4
Mechanistic profiling of the siRNA delivery dynamics of lipid-polymer hybrid nanoparticles.脂质-聚合物杂化纳米颗粒的 siRNA 递药动力学的机制分析。
J Control Release. 2015 Mar 10;201:22-31. doi: 10.1016/j.jconrel.2014.12.026. Epub 2014 Dec 23.
5
Physico-chemical characterisation and transfection efficiency of lipid-based gene delivery complexes.基于脂质的基因递送复合物的物理化学表征及转染效率
Int J Pharm. 1999 Jun 25;183(2):195-207. doi: 10.1016/s0378-5173(99)00117-9.
6
Chitosan-lipid nanoparticles (CS-LNPs): Application to siRNA delivery.壳聚糖脂质纳米粒(CS-LNPs):在 siRNA 递送中的应用。
J Colloid Interface Sci. 2018 Jan 15;510:45-56. doi: 10.1016/j.jcis.2017.09.045. Epub 2017 Sep 11.
7
Engineering of small interfering RNA-loaded lipidoid-poly(DL-lactic-co-glycolic acid) hybrid nanoparticles for highly efficient and safe gene silencing: A quality by design-based approach.载小分子干扰 RNA 的脂质体-聚(DL-乳酸-共-乙醇酸)杂化纳米粒的工程化:基于质量源于设计的方法用于高效和安全的基因沉默。
Eur J Pharm Biopharm. 2017 Nov;120:22-33. doi: 10.1016/j.ejpb.2017.07.014. Epub 2017 Jul 26.
8
Optimization of DOTAP/chol Cationic Lipid Nanoparticles for mRNA, pDNA, and Oligonucleotide Delivery.DOTAP/胆固醇阳离子脂质纳米粒用于 mRNA、pDNA 和寡核苷酸递药的优化。
AAPS PharmSciTech. 2022 May 9;23(5):135. doi: 10.1208/s12249-022-02294-w.
9
Inside out: optimization of lipid nanoparticle formulations for exterior complexation and in vivo delivery of saRNA.从内到外:用于 saRNA 外部复合和体内递释的脂质纳米粒制剂的优化。
Gene Ther. 2019 Sep;26(9):363-372. doi: 10.1038/s41434-019-0095-2. Epub 2019 Jul 12.
10
Enhanced transfection efficiency and reduced cytotoxicity of novel lipid-polymer hybrid nanoplexes.新型脂质-聚合物杂化纳米复合物的转染效率增强和细胞毒性降低。
Mol Pharm. 2013 Jun 3;10(6):2416-25. doi: 10.1021/mp400036w. Epub 2013 May 1.

引用本文的文献

1
A modular polymer platform for efficient mRNA delivery in cancer immunotherapy.一种用于癌症免疫治疗中高效递送信使核糖核酸的模块化聚合物平台。
Nanoscale Horiz. 2025 Aug 7. doi: 10.1039/d5nh00299k.
2
Lipid nanoparticles: a promising tool for nucleic acid delivery in cancer immunotherapy.脂质纳米颗粒:癌症免疫治疗中核酸递送的一种有前景的工具。
Med Oncol. 2025 Aug 6;42(9):409. doi: 10.1007/s12032-025-02939-3.
3
Immunologically effective biomaterials-enhanced vaccines against infection of pathogenic microorganisms.免疫有效生物材料增强型疫苗预防病原微生物感染

本文引用的文献

1
The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs.Onpattro的故事以及含核酸类药物的纳米药物的临床转化。
Nat Nanotechnol. 2019 Dec;14(12):1084-1087. doi: 10.1038/s41565-019-0591-y.
2
Lipid-polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives.脂质-聚合物杂化纳米颗粒作为下一代药物传递平台:现状、新兴技术和展望。
Int J Nanomedicine. 2019 Mar 19;14:1937-1952. doi: 10.2147/IJN.S198353. eCollection 2019.
3
Lipid-polymer hybrid nanoparticles: Synthesis strategies and biomedical applications.
Biosaf Health. 2022 Dec 2;5(1):45-61. doi: 10.1016/j.bsheal.2022.11.002. eCollection 2023 Feb.
4
Challenges and advances of the stability of mRNA delivery therapeutics.mRNA递送疗法稳定性的挑战与进展
Nucl Acid Insights. 2024 Mar;1(2):101-113. doi: 10.18609/nai.2024.015. Epub 2024 Mar 13.
5
Messenger RNA Lipid-Based Nanoparticles: Optimization of Formulations in the Lab.信使核糖核酸脂质纳米颗粒:实验室配方的优化
Methods Mol Biol. 2024;2786:255-287. doi: 10.1007/978-1-0716-3770-8_12.
6
RP-HPLC-CAD method for the rapid analysis of lipids used in lipid nanoparticles derived from dual centrifugation.采用反相高效液相色谱-蒸发光散射检测法快速分析双离心法制备的脂质纳米粒中使用的脂质。
Int J Pharm X. 2024 May 4;7:100255. doi: 10.1016/j.ijpx.2024.100255. eCollection 2024 Jun.
7
Tools shaping drug discovery and development.塑造药物发现与开发的工具。
Biophys Rev (Melville). 2022 Jul 27;3(3):031301. doi: 10.1063/5.0087583. eCollection 2022 Sep.
8
Optimizing the Delivery of mRNA to Mesenchymal Stem Cells for Tissue Engineering Applications.优化 mRNA 向间充质干细胞的传递在组织工程应用中的应用。
Mol Pharm. 2024 Apr 1;21(4):1662-1676. doi: 10.1021/acs.molpharmaceut.3c00898. Epub 2024 Mar 19.
9
Neoantigen vaccine nanoformulations based on Chemically synthesized minimal mRNA (CmRNA): small molecules, big impact.基于化学合成最小化信使核糖核酸(CmRNA)的新抗原疫苗纳米制剂:小分子,大作用。
NPJ Vaccines. 2024 Jan 18;9(1):14. doi: 10.1038/s41541-024-00807-1.
10
Preparation of Nanosized Pharmaceutical Formulations by Dual Centrifugation.通过双重离心法制备纳米级药物制剂
Pharmaceuticals (Basel). 2023 Oct 25;16(11):1519. doi: 10.3390/ph16111519.
脂质-聚合物杂化纳米粒子:合成策略与生物医学应用。
J Microbiol Methods. 2019 May;160:130-142. doi: 10.1016/j.mimet.2019.03.017. Epub 2019 Mar 18.
4
Neutron scattering in the biological sciences: progress and prospects.中子散射在生物科学中的应用:进展与展望。
Acta Crystallogr D Struct Biol. 2018 Dec 1;74(Pt 12):1129-1168. doi: 10.1107/S2059798318017503. Epub 2018 Dec 20.
5
Investigation of charge ratio variation in mRNA - DEAE-dextran polyplex delivery systems.mRNA - DEAE-葡聚糖聚集体传递系统中电荷量比变化的研究。
Biomaterials. 2019 Feb;192:612-620. doi: 10.1016/j.biomaterials.2018.10.020. Epub 2018 Nov 17.
6
Monitoring Translation Activity of mRNA-Loaded Nanoparticles in Mice.监测载 mRNA 纳米颗粒在小鼠体内的翻译活性。
Mol Pharm. 2018 Sep 4;15(9):3909-3919. doi: 10.1021/acs.molpharmaceut.8b00370. Epub 2018 Aug 9.
7
Progress and challenges towards targeted delivery of cancer therapeutics.癌症治疗靶向递药的进展与挑战。
Nat Commun. 2018 Apr 12;9(1):1410. doi: 10.1038/s41467-018-03705-y.
8
Incorporation of mRNA in Lamellar Lipid Matrices for Parenteral Administration.将 mRNA 纳入层状脂质基质用于肠胃外给药。
Mol Pharm. 2018 Feb 5;15(2):642-651. doi: 10.1021/acs.molpharmaceut.7b01022. Epub 2018 Jan 18.
9
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer.个体化 RNA 突变疫苗可动员针对癌症的多特异性治疗性免疫。
Nature. 2017 Jul 13;547(7662):222-226. doi: 10.1038/nature23003. Epub 2017 Jul 5.
10
Prospects for RNA delivery with nanotechnologies.
Gene Ther. 2017 Mar;24(3):121. doi: 10.1038/gt.2017.15.